Sort by
Refine Your Search
-
will be 9:30 AM - 6 PM, Monday-Friday. The Patient Representative (PR) is the "first impression" a patient has of Dana-Farber Cancer Institute (DFCI), and is critical to a patient?s experience and their
-
conduct independent research and development programs. This position reports to the Chief of Physics. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life
-
and an understanding of the principles and practices of clinical research. The Mission, Vision and Core values of the Dana-Farber Cancer Institute are incorporated into all areas of practice. This role
-
The Gastrointestinal (GI) Oncology Clinical Research Program at Dana-Farber Cancer Institute is seeking a Research Data Specialist to join our program. The GI Oncology Clinical Research Program supports PI initiated
-
imaging services ordered by Dana-Farber Cancer Institute (DFCI) providers. Working in a fast-paced, high-volume, dynamic environment, the Radiology Authorization Specialist understands payer coverage
-
of computers, Microsoft applications and databases. Requires experience with medical terminology. At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment
-
talented research technician to join our team at Dana-Farber Cancer Institute / Harvard Medical School. Our lab uses state-of-the-art molecular cellular and genetic approaches to study cancer therapy
-
Advisor for Research Strategy & Operations is a key strategic partner to Dana-Farber Cancer Institute?s Chief Scientific Officer (CSO), providing leadership and operational support for specific high
-
Mission, Vision and Core Values. This position will weekend rotation coverage. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in
-
requirements and patient results. Hours will be from 10:00am - 6:30pm, Monday through Friday with rotating weekends. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in